, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

Neutral BCR
down 24.74 %

C.r. Bard, Inc. (BCR) upgraded to Neutral by Goldman

Posted on: Wednesday,  Oct 23, 2013  8:25 AM ET by Goldman

Goldman rated Neutral C.r. Bard, Inc. (NYSE: BCR) on 10/23/2013. Previously Goldman rated Sell C.r. Bard, Inc. (NYSE: BCR) on 02/22/2013.,
when the stock price was $97.71. Since then, C.r. Bard, Inc. has gained 32.87% as of 10/23/2013's recent price of $129.83.
If you would have followed the previous Goldman's recommendation on BCR, you would have lost 24.74% of your investment in 243 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2013 8:25 AM Hold
as of 12/13/2013
1 Week   
1 Month   
3 Months down  -9.45 %
1 YTD down  -32.87 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/22/2013 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy